SCellex
Spatial and bulk 3' RNA-seq tools and services for single-cell gene expression research in biotech and life sciences
Highlights
- New on EvolcAdded 2026-10-30
About SCellex
SCellex develops a patent-pending visual barcoding technology for spatial single-cell gene expression studies, using arrays of picowells loaded with colour-coded beads that are imaged and analysed with AI to capture RNA from tissue sections or cell suspensions. It also offers 3' bulk RNA-seq services, including 3B-seq for isolated RNA, FFPE-seq for FFPE tissues and Direct-seq for low-input samples, with samples processed in Finland.
The products are sold for research use only to researchers in life sciences, with a stated focus on cancer research. The company sells its arrays and visual barcoding beads, and provides RNA-seq services where customers send samples and receive count tables and analysis.
SCellex is a Finnish biotech company headquartered in Helsinki and was founded in 2018. Its team is listed on its website with R&D scientists and a CEO, and its founder serves as chair of the board.
Product: Visual-barcoded picowell arrays and beads for spatial single-cell RNA capture, plus 3' bulk RNA-seq services.
Jobs at SCellex
Leadership
- Päivi Saavalainen · Founder, CoB, CSOSource: company website
- Arto Forsberg · CEOSource: company website
More biotech & pharma companies
SpringDNA
Environmental DNA sampling and laboratory analysis for biodiversity monitoring and impact assessmentsYoung companyNew on EvolcSuomen Lääkekehityskeskus
State-owned Finnish company that helps university researchers take drug compounds from early discovery to clinical studiesYoung companyNew on EvolcSwitchPoint Bio
Epigenomics and AI platform for biopharma and clinical research teams developing biomarkers and stratifying patientsYoung companyNew on EvolcSymeres Finland
Preclinical ADME-Tox research services for pharmaceutical and biotechnology companiesNew on EvolcSynbio Powerlabs
Bioprocess research and pilot-scale fermentation services for biotechnology companiesYoung companyNew on EvolcTenboron
Develops boron carriers for neutron capture cancer radiotherapy, with lead candidate TB0010 for head and neck cancerNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Complianz
- Google reCAPTCHA
- PHP
- WooCommerce
- WordPress
- jQuery
- nginx
